Search

RISK LEVEL STRATIFICATION USING CIRCULATING TUMOR DNA IN HEAD AND NECK CANCER PATIENTS

Cancer Biology

Liyona Kampel, MD, PhD; Sara Davidova, MD; Shlomo Zuriel, PhD; Narin Carmel Neiderman, MD; Dov Hershkovitz, MD, PhD; Nidal Muhanna, MD, PhD

Tel Aviv Sourasky Medical Center

EVEROLIMUS INHIBITS P53 MUTANT HNSCC BY MODULATING ANGIOGENESIS AND LYMPHANGIOGENESIS MECHANISMS LINKED TO MTOR/HIF1A/VEGF SIGNALING

Cancer Biology

Janmaris Marin Fermin; Md Maksudul Alam, PhD; Kyle A Boudreaux, MS, IV; Landon D Goodreau; Taylor L Powell; Tara Moore-Medlin; Xiaohua Rong; Jerry McLarty; Xin Gu; Cherie-Ann O Nathan

LSU-Health Shreveport

RADIATION IMPROVES THE THERAPEUTIC ANTIBODY DELIVERY IN HEAD AND NECK CANCERS.

Cancer Biology

Laura Freeman, MD; Guolan Lu, PhD; Eben Rosenthal

Stanford

CHARACTERIZING THE TUMOR MICROENVIRONMENT OF IMMUNOSUPPRESSED CUTANEOUS SQUAMOUS CELL CARCINOMA

Cancer Biology

Mica Glaun, MD¹; Frederico Gleber-Netto, PhD¹; Priyadharsini Nagarajan, MD¹; Tongxin Xie¹; Jennifer Covello¹; Shamima Akhter¹; Adebayo Adewale¹; Erez Baruch¹; Michael Wong¹; Kenneth Tsai²; Elsa Flores²; Michael Migden¹; Deborah Silverman¹; Ryan Goepfert¹; Yejing Ge¹; Padamanee Sharma¹; James Allison¹; Jeffrey Myers¹; Neil Gross¹; Moran Amit¹

¹MD Anderson Cancer Center; ²Moffitt Cancer Center

MASS SPECTROMETRY IMAGING OF THE METABOLIC LANDSCAPE OF HUMAN PAPILLOMAVIRUS-ASSOCIATED VERSUS CARCINOGEN-DRIVEN HEAD AND NECK SQUAMOUS CELL CARCINOMA

Cancer Biology

Richard A Harbison, MD¹; William Andrews²; Rajeev Pandey¹; Rebecca Dempsey¹; Rajarsi Mandal¹; Robert Casero¹; Drew Pardoll¹; Carole Fakhry¹; Maureen Kane²; Jonathan Powell¹; Erika Pearce¹

¹Johns Hopkins Hospital; ²University of Maryland